ALL vs ELV
Allstate Corp. and Elevance Health, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | ALL | ELV |
|---|---|---|
| Revenue | $67.7B | $199.1B |
| Net income | $10.3B | $5.7B |
| Gross margin | — | 89.4% |
| Net margin | 15.2% | 2.8% |
| Return on equity | 39.5% | 13.3% |
| Diluted EPS | $38.06 | $25.21 |
| Dividend / share | $4.00 | $5.92 |
| Payout ratio | 10.1% | 27.0% |
| Free cash flow | $9.9B | $3.2B |
| Equity | $30.6B | $43.9B |
| Net debt / equity | 0.22× | 0.51× |
| Current ratio | — | 1.54× |
| Revenue CAGR 5y | 10.1% | 10.3% |
| Profit CAGR 5y | 13.0% | 4.4% |
ELV bills 2.9× the revenue of ALL, and ALL keeps more of each dollar of revenue as profit (15.2% against 2.8%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | ALL | ELV |
|---|---|---|
| FY2025 | $67.7B | $199.1B |
| FY2024 | $64.1B | $177.0B |
| FY2023 | $57.1B | $171.3B |
| FY2022 | $51.4B | $156.6B |
| FY2021 | $50.6B | $138.6B |
| FY2020 | $41.9B | $121.9B |
| FY2019 | $41.5B | $104.2B |
| FY2018 | $39.8B | $92.1B |
| FY2017 | $39.4B | $90.0B |
| FY2016 | $37.4B | $84.9B |
Net income by year
Bottom line
| Fiscal year | ALL | ELV |
|---|---|---|
| FY2025 | $10.3B | $5.7B |
| FY2024 | $4.7B | $6.0B |
| FY2023 | $-188.0M | $6.0B |
| FY2022 | $-1.3B | $5.9B |
| FY2021 | $1.6B | $6.2B |
| FY2020 | $5.6B | $4.6B |
| FY2019 | $4.8B | $4.8B |
| FY2018 | $2.2B | $3.8B |
| FY2017 | $3.6B | $3.8B |
| FY2016 | $1.9B | $2.5B |
Advertisement
AdSense · Rectangle 336×280